Drug interactions
Bazedoxifene-conjugated estrogens + Topiramate
Severity: Minor
Bazedoxifene-conjugated estrogens and Topiramate: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Topiramate is a weak CYP3A4 inducer at higher doses and can modestly reduce exposure to estrogens. This may lessen symptom control or endometrial protection, although the effect is usually small at low doses.
What this interaction means in plain words
Bazedoxifene-conjugated estrogens and Topiramate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Bazedoxifene-conjugated estrogens belongs to Endocrine; Topiramate belongs to Central Nervous System.
Why it happens
Dose-dependent weak induction of CYP3A4 increases estrogen clearance.
What to do
Be aware of the possibility of reduced hormone effect at topiramate doses above about 200 mg daily. Report breakthrough bleeding or recurrent menopausal symptoms for evaluation.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Bazedoxifene-conjugated estrogens and Topiramate, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Bazedoxifene-conjugated estrogens
- Anastrozole + Bazedoxifene-conjugated estrogens Contraindicated
- Bazedoxifene-conjugated estrogens + Ospemifene Contraindicated
- Antithrombin alfa + Bazedoxifene-conjugated estrogens Major
- Antithrombin iii + Bazedoxifene-conjugated estrogens Major
- Bazedoxifene-conjugated estrogens + Bemiparin Major
- Bazedoxifene-conjugated estrogens + Carbamazepine Major
Other interactions of Topiramate
Frequently asked questions
Can I take Bazedoxifene-conjugated estrogens with Topiramate?
MediHelp rates the interaction as minor. Bazedoxifene-conjugated estrogens and Topiramate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Topiramate is a weak CYP3A4 inducer at higher doses and can modestly reduce exposure to estrogens. This may lessen symptom control or endometrial protection, although the effect is usually small at low doses.
How serious is the interaction between Bazedoxifene-conjugated estrogens and Topiramate?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Be aware of the possibility of reduced hormone effect at topiramate doses above about 200 mg daily. Report breakthrough bleeding or recurrent menopausal symptoms for evaluation.
What other medicines interact with Bazedoxifene-conjugated estrogens?
MediHelp also lists interactions of Bazedoxifene-conjugated estrogens with, for example, Anastrozole, Ospemifene, Antithrombin alfa. The full list is on the Bazedoxifene-conjugated estrogens page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
